Houston, we have a problem – narrowly focused care is not the bridge to recovery we need

Reflecting on articles on addiction and recovery that has come my way over the last week. Some encouraging, some more than a bit worrisome. In this post, I will try to weave them together in the context of long-term recovery. History shows us that framing addiction in narrow, single drug strategies sets us up time … Continue reading Houston, we have a problem – narrowly focused care is not the bridge to recovery we need

Pediatric use of buprenorphine

Drugfree.org has a piece advocating more use of buprenorphine with children. Medication-Assisted Treatment (MAT) for opioid dependence is a science-based and proven-effective option for teens and young adults. It should be administered with age appropriate psychosocial therapy and drug testing. Unfortunately, it has been subject to controversy and stigma. Yet the neuroscience of addiction and … Continue reading Pediatric use of buprenorphine

Addiction Treatment With a Dark Side

The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side

Feds raid Reckitt Benckiser offices; criminal probe underway

Hmmm. All is not well with the manufacturer of Suboxone. Reckitt Benckiser’s offices in Richmond, Va., were raided by a team of IRS and Office of Inspector General (OIG) agents on December  3rd. No one is saying what the feds are investigating, but here is some legal analysis. The search warrant, which company officials say … Continue reading Feds raid Reckitt Benckiser offices; criminal probe underway

Suboxone diversion?

A recent study looking at diversion of buprenorphine finds that: While 9% reported recent street-obtained buprenorphine use, only a small minority reported using buprenorphine to get high, with the majority reporting use to manage withdrawal symptoms. The use of street-obtained buprenorphine primarily to avoid withdrawal fits with Dawn Farm’s experience, though the percentage would be … Continue reading Suboxone diversion?

Two more defenses of Suboxone

In the Washington Post, Harold Pollack interviewed Peter Friedmann about buprenorphine and the NY Times series on buprenorphine. We’re fortunate that that they share their premises. HP: Buprenorphine provides a “substitution therapy” for people with opiate disorders. PF: Correct. For many years, opiate addiction was considered an incurable illness. It was Dole and Nyswander in New York who proposed … Continue reading Two more defenses of Suboxone